321 |
What Makes Endeavor Different |
Alan C. Yeung |
Sep. 28. 07 |
320 |
Endeavor - Combining Safety with Efficacy |
Eulogio Garcia |
Sep. 28. 07 |
319 |
Endeavor Clinical Program Overview |
Marco A. Costa |
Sep. 28. 07 |
318 |
Visionable Performance of Next Generation of DES |
Duncan Hung Kwong Ho |
Sep. 20. 07 |
317 |
The J-Cypher Registry Update |
Takeshi Kimura |
Sep. 20. 07 |
316 |
Is DES Deployment Technique Associated with Late Stent Thrombosis?; New Insights from the STLLR Trial |
Marco A. Costa |
Sep. 20. 07 |
315 |
Next Generation of DES |
Alexandre Abizaid |
Sep. 20. 07 |
314 |
Two-Year Follow Up of a First-in-Man Registry with a Bioabsorbable Polymer Based Sirolimus-Eluting Stent (Medistra Excel Drug-Eluting Stent Trial - MEDISTRA Study) |
Teguh Santoso |
Sep. 20. 07 |
313 |
How Can We Optimize Good Result in the Long Coronary Lesion ? |
Seung-Jung Park |
Sep. 07. 07 |
312 |
Chronic Total Occlusions |
David E. Kandzari |
Sep. 07. 07 |